query	target	qheader	theader	fident	alnlen	mismatch	qstart	qend	tstart	tend	evalue	bits
LOKIASV2_4415_ESMFold_ribonuclease_HII	1io2-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1io2-assembly1.cif.gz_A Crystal structure of type 2 ribonuclease h from hyperthermophilic archaeon, thermococcus kodakaraensis kod1	0.425	216	121	1	216	1	211	4.495E-27	995
LOKIASV2_4415_ESMFold_ribonuclease_HII	2dfh-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	2dfh-assembly1.cif.gz_A Crystal structure of Tk-RNase HII(1-212)-C	0.433	216	119	1	216	1	211	1.199E-25	924
LOKIASV2_4415_ESMFold_ribonuclease_HII	2dff-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	2dff-assembly1.cif.gz_A Crystal structure of Tk-RNase HII(1-204)-C	0.431	211	117	1	211	1	206	2.986E-25	909
LOKIASV2_4415_ESMFold_ribonuclease_HII	1uax-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	1uax-assembly2.cif.gz_B Crystal structure of the ribonuclease H2 from Pyrococcus horikoshii OT3	0.387	214	128	1	214	1	209	1.639E-24	898
LOKIASV2_4415_ESMFold_ribonuclease_HII	2dfe-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	2dfe-assembly1.cif.gz_A Crystal structure of Tk-RNase HII(1-200)-C	0.429	213	118	1	213	1	208	1.209E-24	859
LOKIASV2_4415_ESMFold_ribonuclease_HII	1x1p-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1x1p-assembly1.cif.gz_A Crystal structure of Tk-RNase HII(1-197)-A(28-42)	0.435	200	110	1	200	1	195	7.561E-23	777
LOKIASV2_4415_ESMFold_ribonuclease_HII	1eke-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1eke-assembly1.cif.gz_A CRYSTAL STRUCTURE OF CLASS II RIBONUCLEASE H (RNASE HII) WITH MES LIGAND	0.352	215	135	1	209	1	215	6.028E-21	699
LOKIASV2_4415_ESMFold_ribonuclease_HII	1eke-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	1eke-assembly1.cif.gz_B CRYSTAL STRUCTURE OF CLASS II RIBONUCLEASE H (RNASE HII) WITH MES LIGAND	0.364	222	135	1	213	1	222	1.595E-20	682
LOKIASV2_4415_ESMFold_ribonuclease_HII	3p83-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	3p83-assembly1.cif.gz_F Structure of the PCNA:RNase HII complex from Archaeoglobus fulgidus.	0.318	207	133	3	209	2	197	1.136E-17	609
LOKIASV2_4415_ESMFold_ribonuclease_HII	3p83-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	3p83-assembly1.cif.gz_E Structure of the PCNA:RNase HII complex from Archaeoglobus fulgidus.	0.318	204	131	1	204	1	193	8.378E-18	607
LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly3.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly3.cif.gz_G Crystal structure of human RNase H2 complex	0.297	216	146	2	209	21	236	4.970E-15	491
LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly1.cif.gz_A Crystal structure of human RNase H2 complex	0.294	213	146	2	209	29	241	1.031E-14	485
LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly5.cif.gz_M	LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly5.cif.gz_M Crystal structure of human RNase H2 complex	0.284	219	150	2	212	28	246	4.677E-15	482
LOKIASV2_4415_ESMFold_ribonuclease_HII	3kio-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3kio-assembly1.cif.gz_A mouse RNase H2 complex	0.291	218	149	2	212	29	246	2.416E-14	463
LOKIASV2_4415_ESMFold_ribonuclease_HII	3p56-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3p56-assembly1.cif.gz_A The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease	0.292	208	142	2	209	20	220	3.081E-14	462
LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly2.cif.gz_D Crystal structure of human RNase H2 complex	0.298	216	145	2	209	28	243	3.274E-14	462
LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly4.cif.gz_J	LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly4.cif.gz_J Crystal structure of human RNase H2 complex	0.301	213	145	2	209	27	239	2.899E-14	461
LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly6.cif.gz_P	LOKIASV2_4415_ESMFold_ribonuclease_HII	3puf-assembly6.cif.gz_P Crystal structure of human RNase H2 complex	0.308	208	143	2	209	25	231	2.567E-14	451
LOKIASV2_4415_ESMFold_ribonuclease_HII	3p5j-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3p5j-assembly1.cif.gz_A The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease	0.295	217	148	2	212	20	236	1.397E-14	444
LOKIASV2_4415_ESMFold_ribonuclease_HII	4py5-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4py5-assembly1.cif.gz_A Thermovibrio ammonificans RNase H3 in complex with 19-mer RNA/DNA	0.213	204	152	1	204	73	266	5.096E-12	385
LOKIASV2_4415_ESMFold_ribonuclease_HII	3p56-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	3p56-assembly2.cif.gz_D The structure of the human RNase H2 complex defines key interaction interfaces relevant to enzyme function and human disease	0.287	208	125	2	209	20	196	6.446E-13	380
LOKIASV2_4415_ESMFold_ribonuclease_HII	7uwe-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7uwe-assembly1.cif.gz_C CryoEM Structure of E. coli Transcription-Coupled Ribonucleotide Excision Repair (TC-RER) complex	0.226	208	141	2	209	6	188	5.416E-12	371
LOKIASV2_4415_ESMFold_ribonuclease_HII	7uwh-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7uwh-assembly1.cif.gz_C CryoEM Structure of E. coli Transcription-Coupled Ribonucleotide Excision Repair (TC-RER) complex bound to ribonucleotide substrate	0.240	208	138	2	209	3	185	4.551E-11	349
LOKIASV2_4415_ESMFold_ribonuclease_HII	3asm-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3asm-assembly1.cif.gz_A Crystal structure of Q54A mutant protein of Bst-RNase HIII	0.148	215	177	3	211	92	306	2.632E-11	349
LOKIASV2_4415_ESMFold_ribonuclease_HII	2d0c-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	2d0c-assembly1.cif.gz_A Crystal structure of Bst-RNase HIII in complex with Mn2+	0.139	212	179	1	209	90	301	4.551E-11	336
LOKIASV2_4415_ESMFold_ribonuclease_HII	3o3g-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3o3g-assembly1.cif.gz_A T. maritima RNase H2 in complex with nucleic acid substrate and calcium ions	0.240	221	146	2	222	12	204	1.536E-10	306
LOKIASV2_4415_ESMFold_ribonuclease_HII	5y9p-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5y9p-assembly1.cif.gz_A Staphylococcus aureus RNase HII	0.173	212	149	3	214	31	211	7.024E-10	298
LOKIASV2_4415_ESMFold_ribonuclease_HII	3o3h-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3o3h-assembly1.cif.gz_A T. maritima RNase H2 D107N in complex with nucleic acid substrate and manganese ions	0.251	221	144	2	222	12	204	5.853E-10	283
LOKIASV2_4415_ESMFold_ribonuclease_HII	3vn5-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3vn5-assembly1.cif.gz_A Crystal structure of Aquifex aeolicus RNase H3	0.208	199	143	3	201	72	252	5.226E-09	272
LOKIASV2_4415_ESMFold_ribonuclease_HII	2etj-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	2etj-assembly1.cif.gz_A Crystal structure of Ribonuclease HII (EC 3.1.26.4) (RNase HII) (tm0915) from THERMOTOGA MARITIMA at 1.74 A resolution	0.235	221	139	2	222	13	195	2.370E-09	250
LOKIASV2_4415_ESMFold_ribonuclease_HII	4hht-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4hht-assembly1.cif.gz_A T. maritima RNase H2 G21S in complex with nucleic acid substrate and calcium ions	0.224	221	142	2	222	12	195	7.527E-09	235
LOKIASV2_4415_ESMFold_ribonuclease_HII	2nrz-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	2nrz-assembly2.cif.gz_B Crystal structure of the C-terminal half of UvrC bound to its catalytic divalent cation	0.104	189	143	2	190	22	182	4.907E-02	53
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ozr-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ozr-assembly1.cif.gz_B Crystal structure of Mus musculus (Mm) Endonuclease V in complex with a 23mer RNA oligo containing an inosine after a 15 min soak in 10 mM Mg2+	0.119	109	70	2	110	42	122	3.042E-01	42
LOKIASV2_4415_ESMFold_ribonuclease_HII	4z4f-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4z4f-assembly1.cif.gz_A Human Argonaute2 Bound to t1-DAP Target RNA	0.143	132	94	2	133	548	658	3.651E-01	34
LOKIASV2_4415_ESMFold_ribonuclease_HII	3ea0-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3ea0-assembly1.cif.gz_A Crystal Structure of ParA Family ATPase from Chlorobium tepidum TLS	0.166	90	65	83	161	149	238	1.760E-01	33
LOKIASV2_4415_ESMFold_ribonuclease_HII	4z4h-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4z4h-assembly1.cif.gz_A Human Argonaute2 A481T Mutant Bound to t1-A Target RNA	0.141	124	84	2	125	549	647	5.258E-01	32
LOKIASV2_4415_ESMFold_ribonuclease_HII	8h7i-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8h7i-assembly2.cif.gz_B Structure of nanobody 11A in complex with quinalphos	0.166	30	24	1	30	1	30	1.159E+00	29
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ssi-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ssi-assembly1.cif.gz_F Structure of the pentameric ligand-gated ion channel ELIC in complex with a PAM nanobody	0.107	28	24	1	28	1	28	1.026E+00	28
LOKIASV2_4415_ESMFold_ribonuclease_HII	6xw5-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6xw5-assembly1.cif.gz_C Crystal structure of murine norovirus P domain in complex with Nanobody NB-5820	0.148	27	22	1	27	1	27	1.309E+00	28
LOKIASV2_4415_ESMFold_ribonuclease_HII	8hr2-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8hr2-assembly1.cif.gz_B Ternary Crystal Complex Structure of RBD with NB1B5 and NB1C6	0.185	27	21	1	27	1	27	1.391E+00	28
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ul6-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ul6-assembly1.cif.gz_B Crystal Structure of BoNT/A-LCHn domain in complex with VNA ciA-D12/11/ciA-B5 and VHH ciA-H7	0.241	29	21	1	29	1	29	1.091E+00	28
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en4-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en4-assembly1.cif.gz_D Structure of GII.4 norovirus in complex with Nanobody 53	0.185	27	21	1	27	1	27	1.391E+00	27
LOKIASV2_4415_ESMFold_ribonuclease_HII	7xy3-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7xy3-assembly1.cif.gz_D Cryo-EM structure of SARS-CoV-2 spike in complex with VHH14	0.192	26	20	1	26	1	26	9.659E-01	27
LOKIASV2_4415_ESMFold_ribonuclease_HII	7s2r-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7s2r-assembly1.cif.gz_B nanobody bound to IL-2Rg	0.133	30	25	1	30	1	30	1.391E+00	27
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zqt-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zqt-assembly1.cif.gz_C Helicobacter pylori adhesin BabA bound to neutralising human antibody.	0.172	29	23	1	29	1	29	1.571E+00	27
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en4-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en4-assembly1.cif.gz_C Structure of GII.4 norovirus in complex with Nanobody 53	0.185	27	21	1	27	1	27	1.670E+00	26
LOKIASV2_4415_ESMFold_ribonuclease_HII	1zvh-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1zvh-assembly1.cif.gz_A Crystal structure of the VHH domain D2-L24 in complex with hen egg white lysozyme	0.148	27	22	1	27	1	27	2.130E+00	26
LOKIASV2_4415_ESMFold_ribonuclease_HII	5e0q-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5e0q-assembly1.cif.gz_A Crystal structure of the Nup98 C-terminal domain bound to nanobody TP377	0.153	26	21	1	26	1	26	2.130E+00	26
LOKIASV2_4415_ESMFold_ribonuclease_HII	6jb5-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6jb5-assembly1.cif.gz_A Crystal structure of nanobody D3-L11 mutant Y102A in complex with hen egg-white lysozyme (form II)	0.148	27	22	1	27	1	27	2.004E+00	26
LOKIASV2_4415_ESMFold_ribonuclease_HII	4dka-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4dka-assembly2.cif.gz_B Structure of Editosome protein	0.148	27	22	1	27	1	27	2.130E+00	26
LOKIASV2_4415_ESMFold_ribonuclease_HII	6dbd-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6dbd-assembly2.cif.gz_B Crystal Structure of VHH R326	0.185	27	21	1	27	1	27	2.716E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7r24-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7r24-assembly1.cif.gz_C Crystal structure of rat Arc CTD in complex with two anti-Arc nanobodies	0.148	27	22	1	27	1	27	2.130E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7nvm-assembly1.cif.gz_n	LOKIASV2_4415_ESMFold_ribonuclease_HII	7nvm-assembly1.cif.gz_n Human TRiC complex in closed state with nanobody Nb18, actin and PhLP2A bound	0.153	26	21	1	26	1	26	2.556E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7a48-assembly1.cif.gz_A-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	7a48-assembly1.cif.gz_A-2 Crystal structure of the APH coiled-coil in complex with Nb49	0.148	27	22	1	27	1	27	2.716E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	8ftg-assembly3.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	8ftg-assembly3.cif.gz_F Biophysical and Structural Characterization of an Anti-Caffeine VHH Antibody	0.133	30	25	1	30	3	32	2.405E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7p60-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7p60-assembly1.cif.gz_H Structure of homomeric LRRC8A Volume-Regulated Anion Channel in complex with synthetic nanobody Sb4 at 1:0.5 ratio	0.148	27	22	1	27	1	27	2.556E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	3eak-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3eak-assembly2.cif.gz_B NbBCII10 humanized (FGLA mutant)	0.137	29	24	1	29	1	29	2.556E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	5jds-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5jds-assembly1.cif.gz_B Crystal structure of PD-L1 complexed with a nanobody at 1.7 Angstron resolution	0.137	29	24	1	29	1	29	2.130E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cml-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cml-assembly1.cif.gz_C Cryo-EM structure of complement C5 in complex with nanobodies UNbC5-1 and UNbC5-2	0.153	26	21	1	26	1	26	2.004E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	6f0d-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6f0d-assembly2.cif.gz_A Crystal structure of a llama VHH antibody BCD090-M2 against human ErbB3 in space group P1 with cadmium ions	0.133	30	25	1	30	2	31	2.004E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en1-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en1-assembly1.cif.gz_D Structure of GII.4 norovirus in complex with Nanobody 30	0.185	27	21	1	27	1	27	2.556E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7ldj-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7ldj-assembly1.cif.gz_E SARS-CoV-2 receptor binding domain in complex with WNb-2	0.153	26	21	1	26	1	26	2.004E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7n0i-assembly4.cif.gz_L	LOKIASV2_4415_ESMFold_ribonuclease_HII	7n0i-assembly4.cif.gz_L Structure of the SARS-CoV-2 N protein C-terminal domain bound to single-domain antibody E2	0.172	29	22	2	29	4	32	2.004E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	8sk5-assembly1.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	8sk5-assembly1.cif.gz_B-2 Crystal structure of the SARS-CoV-2 neutralizing VHH 7A9 bound to the spike receptor binding domain	0.133	30	25	1	30	1	30	2.263E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7nxx-assembly1.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	7nxx-assembly1.cif.gz_B-2 Structure of Superoxide Dismutase 1 (SOD1) in complex with nanobody 2 (Nb2).	0.214	28	21	1	28	3	30	2.556E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	6xym-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6xym-assembly1.cif.gz_A Nbe-LBM	0.153	26	21	1	26	1	26	2.716E+00	25
LOKIASV2_4415_ESMFold_ribonuclease_HII	7ndf-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7ndf-assembly2.cif.gz_D Crystal structure of nanobody Nb_MsbA#1 in complex with the nucleotide binding domain of MsbA	0.161	31	24	1	30	1	31	1.478E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ul6-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ul6-assembly1.cif.gz_C Crystal Structure of BoNT/A-LCHn domain in complex with VNA ciA-D12/11/ciA-B5 and VHH ciA-H7	0.233	30	22	1	30	1	30	2.556E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kd2-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kd2-assembly1.cif.gz_C Ricin bound to VHH antibody V11B2	0.192	26	20	1	26	1	26	2.405E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	5vxl-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5vxl-assembly1.cif.gz_B 2.80 A resolution structure of IpaD from Shigella flexneri in complex with single-domain antibody JPS-G3	0.133	30	25	1	30	1	30	2.556E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7r74-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7r74-assembly2.cif.gz_B Crystal structure of llama VHH antibody in complex with HIV-1 HXBC2 gp120 core	0.185	27	21	1	27	1	27	3.464E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7r4r-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7r4r-assembly1.cif.gz_D The SARS-CoV-2 spike in complex with the 1.10 neutralizing nanobody	0.148	27	22	1	27	1	27	3.067E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	1sjx-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1sjx-assembly1.cif.gz_A Three-Dimensional Structure of a Llama VHH Domain OE7 binding the cell wall protein Malf1	0.148	27	22	1	27	1	27	3.067E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	6itq-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6itq-assembly1.cif.gz_B Crystal structure of cortisol complexed with its nanobody at pH 10.5	0.185	27	21	1	27	1	27	3.067E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7te8-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7te8-assembly2.cif.gz_B CA14-CBD-DB21 ternary complex	0.148	27	22	1	27	2	28	3.260E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	6xw4-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6xw4-assembly1.cif.gz_C Crystal structure of murine norovirus P domain in complex with Nanobody NB-5867	0.153	26	21	1	26	1	26	3.067E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7olz-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7olz-assembly1.cif.gz_B Crystal structure of the SARS-CoV-2 RBD with neutralizing-VHHs Re5D06 and Re9F06	0.137	29	24	1	29	1	29	2.556E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	4kml-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4kml-assembly1.cif.gz_B Probing the N-terminal beta-sheet conversion in the crystal structure of the full-length human prion protein bound to a Nanobody	0.129	31	26	1	31	1	31	2.556E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	6hhd-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6hhd-assembly1.cif.gz_B Mouse Prion Protein in complex with Nanobody 484	0.129	31	26	1	31	1	31	2.405E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	4w6x-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4w6x-assembly1.cif.gz_B Co-complex structure of the lectin domain of F18 fimbrial adhesin FedF with inhibitory nanobody NbFedF7	0.153	26	21	1	26	1	26	3.260E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	4gft-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4gft-assembly1.cif.gz_B Malaria invasion machinery protein-Nanobody complex	0.133	30	25	1	30	1	30	2.130E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	6h70-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6h70-assembly1.cif.gz_D GI.1 human norovirus protruding domain in complex with Nano-62 and 2-fucosyllactose (2FL)	0.148	27	22	1	27	1	27	2.886E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	4s10-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4s10-assembly2.cif.gz_B Gelsolin nanobody shielding mutant plasma gelsolin from furin proteolysis	0.153	26	21	1	26	1	26	2.556E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	5vm0-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5vm0-assembly1.cif.gz_B The hapten triclocarban bound to the single domain camelid nanobody VHH T9	0.115	26	22	2	27	3	28	2.716E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zw1-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zw1-assembly1.cif.gz_C Human PRPH2-ROM1 hetero-dimer	0.137	29	24	1	29	2	30	2.130E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7eow-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7eow-assembly1.cif.gz_B High-resolution structure of vWF A1 domain in complex with caplacizumab, the first nanobody-based medicine	0.153	26	21	1	26	1	26	2.716E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	7now-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7now-assembly2.cif.gz_C Complex of Nucleoporin-98 and nanobody MS98-27 solved at 1.85A resolution	0.148	27	22	1	27	1	27	2.716E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	2x89-assembly5.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	2x89-assembly5.cif.gz_A Structure of the Beta2_microglobulin involved in amyloidogenesis	0.166	30	23	1	29	1	30	1.886E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	6y1r-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6y1r-assembly1.cif.gz_C Nb22-LBT	0.153	26	21	1	26	1	26	2.886E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	5a2i-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5a2i-assembly1.cif.gz_H Crystal structure of scFv-SM3 in complex with APD-SGalNAc-RP	0.133	30	25	1	30	1	30	2.405E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	5the-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5the-assembly2.cif.gz_C Crystal structure of the C-terminal lobe of a budding yeast Argonaute	0.104	125	92	1	125	237	340	1.571E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	5the-assembly4.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	5the-assembly4.cif.gz_G Crystal structure of the C-terminal lobe of a budding yeast Argonaute	0.106	124	91	1	124	241	343	1.091E+00	24
LOKIASV2_4415_ESMFold_ribonuclease_HII	8gni-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8gni-assembly1.cif.gz_C Human SARM1 bounded with NMN and Nanobody-C6, Conformation 1	0.137	29	24	1	29	2	30	2.263E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7cz0-assembly3.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	7cz0-assembly3.cif.gz_G Crystal structure of a thermostable green fluorescent protein (TGP) with a synthetic nanobody (Sb92)	0.153	26	21	1	26	1	26	3.260E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6oq5-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	6oq5-assembly1.cif.gz_F Structure of the full-length Clostridium difficile toxin B in complex with 3 VHHs	0.185	27	21	1	27	1	27	2.716E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	8e1c-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	8e1c-assembly1.cif.gz_A Crystal Structure of Nanobody VHH222 Specific for PA14 Cif	0.133	30	25	1	30	1	30	2.716E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6vbg-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6vbg-assembly2.cif.gz_D Lactose permease complex with thiodigalactoside and nanobody 9043	0.096	31	27	1	31	1	31	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	5usf-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5usf-assembly2.cif.gz_C Leishmania donovani tyrosyl-tRNA synthetase in complex with nanobody and inhibitor	0.137	29	24	1	29	1	29	3.260E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	4m3j-assembly3.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4m3j-assembly3.cif.gz_B Structure of a single-domain camelid antibody fragment cAb-H7S specific of the BlaP beta-lactamase from Bacillus licheniformis	0.133	30	25	1	30	1	30	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	3tpk-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3tpk-assembly1.cif.gz_A Crystal structure of the oligomer-specific KW1 antibody fragment	0.148	27	22	1	27	1	27	3.464E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	4poy-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4poy-assembly1.cif.gz_A Engineered Dual Specific VHH antibody	0.153	26	21	1	26	1	26	2.886E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7t4s-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7t4s-assembly1.cif.gz_H CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with NRP2 and neutralizing fabs 8I21 and 13H11	0.103	29	25	1	29	1	29	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6itq-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6itq-assembly1.cif.gz_D Crystal structure of cortisol complexed with its nanobody at pH 10.5	0.185	27	21	1	27	1	27	3.681E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ze1-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ze1-assembly1.cif.gz_B human NBD1 of CFTR in complex with nanobody G11a	0.153	26	21	1	26	1	26	3.464E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	5nbd-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5nbd-assembly1.cif.gz_C PglK flippase in complex with inhibitory nanobody	0.137	29	24	1	29	1	29	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6u14-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6u14-assembly1.cif.gz_B VHH R303 C33A/C102A in complex withthe LRR domain of InlB	0.153	26	21	1	26	1	26	4.157E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7b5g-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7b5g-assembly2.cif.gz_D Crystal structure of E.coli LexA in complex with nanobody NbSOS3(Nb14527)	0.137	29	24	1	29	1	29	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7usv-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7usv-assembly2.cif.gz_D Plasmodium falciparum protein Pfs230 D1 in complex with nanobody F10	0.137	29	24	1	29	1	29	2.556E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	5boz-assembly5.cif.gz_K	LOKIASV2_4415_ESMFold_ribonuclease_HII	5boz-assembly5.cif.gz_K Ricin A chain bound to camelid nanobody (VHH9)(E1)	0.148	27	22	1	27	3	29	2.556E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	8dp0-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8dp0-assembly1.cif.gz_B Structure of p110 gamma bound to the Ras inhibitory nanobody NB7	0.137	29	24	1	29	1	29	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6itq-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6itq-assembly1.cif.gz_C Crystal structure of cortisol complexed with its nanobody at pH 10.5	0.185	27	21	1	27	1	27	3.681E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	5vl2-assembly2.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	5vl2-assembly2.cif.gz_E The hapten triclocarban bound to the single domain camelid nanobody VHH T4	0.153	26	21	1	26	2	27	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7on5-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7on5-assembly1.cif.gz_A Crystal structure of the SARS-CoV-2 neutralizing nanobody Re5D06	0.153	26	21	1	26	1	26	3.260E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7x2k-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7x2k-assembly1.cif.gz_B Crystal structure of nanobody Nb70 with antibody 1F11 fab and SARS-CoV-2 RBD	0.172	29	23	1	29	1	29	3.067E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7z6v-assembly1.cif.gz_X	LOKIASV2_4415_ESMFold_ribonuclease_HII	7z6v-assembly1.cif.gz_X CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11 nanobody complex	0.148	27	22	1	27	1	27	3.260E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	5m7q-assembly3.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5m7q-assembly3.cif.gz_A Engineering the Thermostability of Nanobodies - NbD2	0.166	24	19	1	24	1	24	2.263E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	6fzq-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6fzq-assembly1.cif.gz_H Crystal structure of scFv-SM3 in complex with compound 3	0.133	30	25	1	30	1	30	2.716E+00	23
LOKIASV2_4415_ESMFold_ribonuclease_HII	7t5f-assembly2.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7t5f-assembly2.cif.gz_E Botulinum neurotoxin Type B Light Chain complexed with nanobodies JLJ-G3 and JNE-B10	0.137	29	24	1	29	1	29	4.157E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	5my6-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5my6-assembly1.cif.gz_B Crystal structure of a HER2-Nb complex	0.148	27	22	1	27	1	27	3.067E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	8ftg-assembly4.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	8ftg-assembly4.cif.gz_G Biophysical and Structural Characterization of an Anti-Caffeine VHH Antibody	0.137	29	24	2	30	4	32	3.260E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	4y5v-assembly2.cif.gz_G-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	4y5v-assembly2.cif.gz_G-2 Diabody 305 complex with EpoR	0.173	23	18	2	24	3	25	2.716E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kjh-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kjh-assembly1.cif.gz_A Plasmodium falciparum protein Pf12p bound to nanobody B9	0.148	27	22	1	27	1	27	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	3dur-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3dur-assembly2.cif.gz_B Crystal structure of SAG173-04	0.129	31	26	1	31	1	31	3.464E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6i6j-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6i6j-assembly1.cif.gz_C Crystal structure of the KDEL receptor bound to synthetic nanobody.	0.153	26	21	1	26	1	26	4.157E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	5o04-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5o04-assembly1.cif.gz_C GII.10 Vietnam 026 norovirus protruding domain in complex with Nanobody Nano-26 and Nano-85	0.148	27	22	1	27	1	27	4.695E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6xzu-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6xzu-assembly1.cif.gz_A Complex of C-terminal domain of murine complement C3b with the hC3Nb3 nanobody	0.166	30	23	1	30	2	30	3.260E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6qgw-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6qgw-assembly1.cif.gz_B Crystal structure of E.coli BamA beta-barrel in complex with nanobody E6	0.137	29	24	1	29	1	29	4.157E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7djy-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7djy-assembly1.cif.gz_A Clec4f Nanobody 322	0.133	30	25	1	30	1	30	4.418E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	1dql-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1dql-assembly1.cif.gz_H CRYSTAL STRUCTURE OF AN UNLIGANDED (NATIVE) FV FROM A HUMAN IGM ANTI-PEPTIDE ANTIBODY	0.137	29	24	1	29	1	29	3.912E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7k7y-assembly4.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7k7y-assembly4.cif.gz_C Crystal structure of BoNT/E LC-HN domain in complex with VHH JLE-E9	0.185	27	21	1	27	1	27	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ui1-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ui1-assembly1.cif.gz_C Crystal structure of BoNT/A-LCHn domain in complex with VHH ciA-D12, ciA-B5, and ciA-H7	0.206	29	22	1	29	1	29	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	4n9o-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4n9o-assembly1.cif.gz_B Probing the N-terminal beta-sheet conversion in the crystal structure of the human prion protein bound to a Nanobody	0.129	31	26	1	31	1	31	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zau-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zau-assembly2.cif.gz_D Fascin-1 in complex with Nb 3E11	0.153	26	21	1	26	1	26	2.886E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	8opr-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8opr-assembly1.cif.gz_C Structure of the EA1 surface layer of Bacillus anthracis	0.172	29	23	1	29	1	29	3.464E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cxr-assembly3.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cxr-assembly3.cif.gz_F Crystal structure of MraY bound to a sphaerimicin analogue	0.161	31	24	1	30	1	31	3.464E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	1mvf-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1mvf-assembly1.cif.gz_A MazE addiction antidote	0.148	27	22	1	27	1	27	3.464E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7rxc-assembly1.cif.gz_N	LOKIASV2_4415_ESMFold_ribonuclease_HII	7rxc-assembly1.cif.gz_N CryoEM structure of KDELR with Legobody	0.153	26	21	1	26	1	26	4.157E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sai-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sai-assembly1.cif.gz_C Crystal Structure of Lag30 Nanobody bound to eGFP	0.148	27	22	1	27	1	27	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6sge-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6sge-assembly1.cif.gz_B Crystal structure of Human RHOB-GTP in complex with nanobody B6	0.153	26	21	1	26	1	26	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	8q94-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8q94-assembly1.cif.gz_C Crystal structure of The SARS-COV-2 BA.2.75 RBD with neutralizing-VHHs Re32D03 and Ma3B12	0.153	26	21	1	26	1	26	3.912E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6sge-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6sge-assembly2.cif.gz_D Crystal structure of Human RHOB-GTP in complex with nanobody B6	0.153	26	21	1	26	1	26	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7z9q-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7z9q-assembly1.cif.gz_D CRYO-EM STRUCTURE OF SARS-COV-2 SPIKE : H11-A10 nanobody complex	0.153	26	21	1	26	1	26	4.418E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	8as0-assembly3.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8as0-assembly3.cif.gz_H PD-1 extracellular domain in complex with Fab fragment from D12 antibody	0.153	26	21	1	26	1	26	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	1sm3-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1sm3-assembly1.cif.gz_H CRYSTAL STRUCTURE OF THE TUMOR SPECIFIC ANTIBODY SM3 COMPLEX WITH ITS PEPTIDE EPITOPE	0.133	30	25	1	30	1	30	3.464E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	6kn9-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6kn9-assembly1.cif.gz_D Crystal structure of human interleukin 18 receptor beta extracellular domain in complex with an antagonistic scFv	0.133	30	25	1	30	6	35	3.464E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	1m7i-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	1m7i-assembly1.cif.gz_B CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A PENTASACCHARIDE	0.133	30	25	1	30	1	30	3.912E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	4rbp-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	4rbp-assembly1.cif.gz_H Crystal structure of HIV neutralizing antibody 2G12 in complex with a bacterial oligosaccharide analog of mammalian oligomanose	0.153	26	21	1	26	1	26	3.260E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	1pkq-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	1pkq-assembly1.cif.gz_B Myelin Oligodendrocyte Glycoprotein-(8-18C5) Fab-complex	0.133	30	25	1	30	1	30	4.157E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	5t6l-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5t6l-assembly2.cif.gz_A Crystal structure of 10E8 Fab in complex with the MPER epitope scaffold T117v2	0.166	30	24	1	30	1	30	3.681E+00	22
LOKIASV2_4415_ESMFold_ribonuclease_HII	7ph2-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7ph2-assembly1.cif.gz_C Nanodisc reconstituted MsbA in complex with nanobodies, spin-labeled at position A60C	0.133	30	25	1	30	1	30	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	1p4i-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1p4i-assembly1.cif.gz_H Crystal Structure of scFv against peptide GCN4	0.166	24	19	1	24	1	24	3.681E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4x7f-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	4x7f-assembly1.cif.gz_D Crystal structure of norovirus GII.10 P domain in complex with Nano-25	0.137	29	24	1	29	1	29	3.464E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5h8d-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5h8d-assembly1.cif.gz_A Crystal structure of an ASC binding nanobody	0.137	29	24	1	29	1	29	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5fv2-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5fv2-assembly2.cif.gz_A Crystal structure of hVEGF in complex with VH domain antibody	0.153	26	21	1	26	1	26	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7jva-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7jva-assembly1.cif.gz_H SARS-CoV-2 spike in complex with the S2A4 neutralizing antibody Fab fragment (local refinement of the receptor-binding domain and Fab variable domains)	0.153	26	21	1	26	1	26	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6mpg-assembly1.cif.gz_W	LOKIASV2_4415_ESMFold_ribonuclease_HII	6mpg-assembly1.cif.gz_W Cryo-EM structure at 3.2 A resolution of HIV-1 fusion peptide-directed antibody, A12V163-b.01, elicited by vaccination of Rhesus macaques, in complex with stabilized HIV-1 Env BG505 DS-SOSIP, which was also bound to antibodies VRC03 and PGT122	0.153	26	21	1	26	1	26	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7spa-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7spa-assembly1.cif.gz_C Chlorella virus Hyaluronan Synthase in the GlcNAc-primed, channel-open state	0.153	26	21	1	26	1	26	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4z5r-assembly7.cif.gz_Z	LOKIASV2_4415_ESMFold_ribonuclease_HII	4z5r-assembly7.cif.gz_Z Rontalizumab Fab bound to Interferon-a2	0.133	30	25	1	30	1	30	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en0-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en0-assembly1.cif.gz_D Structure of GII.17 norovirus in complex with Nanobody 7	0.153	26	21	1	26	1	26	2.556E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	2gsg-assembly3.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	2gsg-assembly3.cif.gz_B Crystal structure of the Fv fragment of a monoclonal antibody specific for poly-glutamine	0.166	30	23	1	30	1	29	3.067E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8be4-assembly1.cif.gz_C000	LOKIASV2_4415_ESMFold_ribonuclease_HII	8be4-assembly1.cif.gz_C000 Crystal structure of SOS1-KRasG12V-Nanobody14	0.148	27	22	1	27	1	27	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6obc-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6obc-assembly1.cif.gz_B Ricin A chain bound to camelid	0.100	30	26	1	30	1	30	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6qup-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6qup-assembly1.cif.gz_B Structural signatures in EPR3 define a unique class of plant carbohydrate receptors	0.148	27	22	1	27	2	28	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7nft-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7nft-assembly2.cif.gz_D Fujian capbinding domain in complex with Nb8208	0.137	29	24	1	29	1	29	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7x8z-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7x8z-assembly1.cif.gz_H The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab188	0.133	30	25	1	30	1	30	3.067E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4mqt-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4mqt-assembly1.cif.gz_B Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist iperoxo and allosteric modulator LY2119620	0.142	28	23	1	28	1	28	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7p2d-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7p2d-assembly1.cif.gz_C Structure of alphaMbeta2/Cd11bCD18 headpiece in complex with a nanobody	0.133	30	25	1	30	2	31	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7x4i-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7x4i-assembly1.cif.gz_H Crystal structure of nanobody aSA3 in complex with dimer SARS-CoV-1 RBD	0.178	27	21	1	27	1	27	3.912E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6yu8-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6yu8-assembly1.cif.gz_B RNA Methyltransferase of Sudan Ebola Virus	0.133	30	25	1	30	1	30	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en3-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en3-assembly1.cif.gz_D Structure of GII.17 norovirus in complex with Nanobody 45	0.153	26	21	1	26	1	26	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6gkd-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6gkd-assembly1.cif.gz_C human NBD1 of CFTR in complex with nanobodies D12 and G3a	0.148	27	22	1	27	1	27	3.464E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sp9-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sp9-assembly1.cif.gz_B Chlorella virus Hyaluronan Synthase in the GlcNAc-primed channel-closed state	0.137	29	24	1	29	1	29	3.912E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7tfn-assembly1.cif.gz_P	LOKIASV2_4415_ESMFold_ribonuclease_HII	7tfn-assembly1.cif.gz_P Cryo-EM structure of CD4bs antibody Ab1303 in complex with HIV-1 Env trimer BG505 SOSIP.664	0.103	29	25	1	29	1	29	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8h3x-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	8h3x-assembly1.cif.gz_A Bacteroide Fragilis Toxin in complex with nanobody 282	0.153	26	21	1	26	1	26	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6hjx-assembly1.cif.gz_J	LOKIASV2_4415_ESMFold_ribonuclease_HII	6hjx-assembly1.cif.gz_J X-ray structure of a pentameric ligand gated ion channel from Erwinia chrysanthemi (ELIC) 7'C pore mutant (L238C) in complex with nanobody 72	0.148	27	22	1	27	1	27	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7o3b-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7o3b-assembly2.cif.gz_B Crystal structure of the TTBK2-CEP164 complex bound to a camelid nanobody	0.192	26	20	1	26	6	31	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5imm-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5imm-assembly1.cif.gz_B Nanobody targeting mouse Vsig4 in Spacegroup P212121	0.137	29	24	1	29	1	29	3.912E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7r24-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7r24-assembly1.cif.gz_E Crystal structure of rat Arc CTD in complex with two anti-Arc nanobodies	0.111	27	23	1	27	1	27	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7e53-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7e53-assembly1.cif.gz_B Crystal structure of sfGFP complexed with the nanobody nb2 at 2.2 Angstron resolution	0.153	26	21	1	26	1	26	5.302E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8sos-assembly1.cif.gz_G-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	8sos-assembly1.cif.gz_G-2 Human CD1d presenting sphingomyelin C24:1 in complex with VHH nanobody 1D17	0.137	29	24	1	29	1	29	3.912E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5u65-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5u65-assembly2.cif.gz_B Camel Nanobody VHH-5	0.208	24	18	1	24	1	24	3.681E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cyj-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cyj-assembly1.cif.gz_C RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25	0.153	26	21	1	26	1	26	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4w6y-assembly1.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	4w6y-assembly1.cif.gz_B-2 Co-complex structure of the lectin domain of F18 fimbrial adhesin FedF with inhibitory nanobody NbFedF9	0.133	30	25	1	30	1	30	3.912E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7ey5-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7ey5-assembly1.cif.gz_H Local CryoEM structure of the SARS-CoV-2 S6PV2 in complex with BD-771 Fab and BD-821 Fab	0.137	29	24	1	29	1	29	3.681E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4lgs-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4lgs-assembly1.cif.gz_B Ricin A chain bound to camelid nanobody (VHH4)	0.172	29	23	1	29	1	29	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6vpx-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6vpx-assembly1.cif.gz_H Nanodisc of full-length HIV-1 Envelope glycoprotein clone AMC011 in complex with one PGT151 Fab and three 10E8 Fabs	0.166	30	24	1	30	1	30	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4qlr-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4qlr-assembly1.cif.gz_A Llama nanobody n02 raised against EAEC T6SS TssM	0.137	29	24	1	29	1	29	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly7.cif.gz_R	LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly7.cif.gz_R Fab fragment of anti-cocaine antibody h2E2 bound to benzoylecgonine	0.153	26	21	1	26	1	26	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5t5b-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5t5b-assembly2.cif.gz_A CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT5 AND T117V2 HIV-1 MPER SCAFFOLD	0.166	30	24	1	30	1	30	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5t5b-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5t5b-assembly1.cif.gz_H CRYSTAL STRUCTURE OF THE COMPLEX OF 10E8 FAB LIGHT CHAIN MUTANT5 AND T117V2 HIV-1 MPER SCAFFOLD	0.166	30	24	1	30	1	30	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6e4z-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6e4z-assembly1.cif.gz_H Anti-PCSK9 fab 6E2 bound to the modified N-terminal peptide from PCSK9	0.133	30	25	1	30	1	30	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zqt-assembly2.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zqt-assembly2.cif.gz_G Helicobacter pylori adhesin BabA bound to neutralising human antibody.	0.172	29	23	1	29	1	29	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	1pkq-assembly2.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	1pkq-assembly2.cif.gz_G Myelin Oligodendrocyte Glycoprotein-(8-18C5) Fab-complex	0.133	30	25	1	30	1	30	5.302E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6mu3-assembly1.cif.gz_M	LOKIASV2_4415_ESMFold_ribonuclease_HII	6mu3-assembly1.cif.gz_M Anti-HIV-1 Fab 2G12 + Man7 re-refinement	0.153	26	21	1	26	1	26	4.157E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	1cz8-assembly1.cif.gz_Y	LOKIASV2_4415_ESMFold_ribonuclease_HII	1cz8-assembly1.cif.gz_Y VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY	0.166	30	24	1	30	1	30	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6d11-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6d11-assembly2.cif.gz_C Crystal structure of 1450 Fab in complex with circumsporozoite protein NANP5	0.153	26	21	1	26	1	26	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ugv-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ugv-assembly1.cif.gz_H Crystal structure of the Fab fragment of anti-TNFa antibody infliximab (Remicade) in a I-centered orthorhombic crystal form, Lot C	0.133	30	25	1	30	1	30	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6azm-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6azm-assembly2.cif.gz_D Crystal structure of the 580 germline antibody bound to circumsporozoite protein NANP 5-mer	0.153	26	21	1	26	1	26	4.989E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	5ik3-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5ik3-assembly2.cif.gz_C Crystal structure of anti-gliadin 1002-1E03 Fab fragment	0.133	30	25	1	30	1	30	4.695E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	4jm2-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4jm2-assembly1.cif.gz_A Crystal Structure of PGT 135 Fab in Complex with gp120 Core Protein from HIV-1 Strain JR-FL Bound to CD4 and 17b Fab	0.185	27	21	1	27	1	27	5.635E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	8dy1-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8dy1-assembly1.cif.gz_C Crystal Structure of scFv CAT2200 LH in complex with IL-17A	0.160	25	20	2	26	113	137	3.912E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	6kr0-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6kr0-assembly1.cif.gz_B Crystal structure of HL homo-diabody	0.133	30	25	1	30	1	30	5.302E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	3grw-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	3grw-assembly1.cif.gz_H FGFR3 in complex with a Fab	0.133	30	25	1	30	1	30	4.418E+00	21
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sr4-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sr4-assembly2.cif.gz_D Single chain trimer HLA-A*02:01 (H98L, Y108C) with HPV.16 E7 peptide YMLDLQPETTDLYC	0.137	29	24	1	29	1	29	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7km5-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7km5-assembly2.cif.gz_C Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1	0.137	29	24	1	29	1	29	4.989E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5dxw-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5dxw-assembly1.cif.gz_A Crystal structure of mouse PD-L1 nanobody	0.153	26	21	1	26	1	26	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8g0w-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8g0w-assembly1.cif.gz_D Crystal structure of human norovirus GII.4 P domain in complex with Nanobody M4	0.148	27	22	1	27	1	27	4.989E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	1yzz-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1yzz-assembly1.cif.gz_A Humanized caban33 at room temperature	0.148	27	22	1	27	1	27	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7nfq-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7nfq-assembly2.cif.gz_D Fujian capmidlink domain in complex with Nb8193	0.161	31	24	1	30	1	31	4.418E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	4w2q-assembly3.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	4w2q-assembly3.cif.gz_E Anti-Marburgvirus Nucleoprotein Single Domain Antibody C Complexed with Nucleoprotein C-terminal domain	0.192	26	20	1	26	1	26	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7t5f-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7t5f-assembly1.cif.gz_B Botulinum neurotoxin Type B Light Chain complexed with nanobodies JLJ-G3 and JNE-B10	0.137	29	24	1	29	2	30	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	4v1d-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4v1d-assembly1.cif.gz_A Ternary complex among two human derived single chain antibody fragments and Cn2 toxin from scorpion Centruroides noxius.	0.137	29	24	1	29	1	29	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	3hb3-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	3hb3-assembly1.cif.gz_C High resolution crystal structure of Paracoccus denitrificans cytochrome c oxidase	0.115	26	22	1	26	1	26	4.989E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6z1z-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6z1z-assembly2.cif.gz_B Structure of the anti-CD9 nanobody 4C8	0.137	29	24	1	29	1	29	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7c8v-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7c8v-assembly1.cif.gz_A Structure of sybody SR4 in complex with the SARS-CoV-2 S Receptor Binding domain (RBD)	0.133	30	25	1	30	1	30	4.989E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5mwn-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	5mwn-assembly1.cif.gz_D Structure of the EAEC T6SS component TssK N-terminal domain in complex with llama nanobodies nbK18 and nbK27	0.148	27	22	1	27	1	27	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6rty-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6rty-assembly1.cif.gz_B Crystal structure of the Patched ectodomain in complex with nanobody NB64	0.166	24	19	1	24	1	24	3.681E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7te8-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7te8-assembly2.cif.gz_D CA14-CBD-DB21 ternary complex	0.148	27	22	1	27	1	27	7.637E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5vxj-assembly4.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5vxj-assembly4.cif.gz_H 2.50 A resolution structure of IpaD from Shigella flexneri in complex with single-domain antibody JMK-E3	0.137	29	24	1	29	1	29	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	2dlf-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	2dlf-assembly1.cif.gz_H HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FV FRAGMENT FROM AN ANTI-DANSYL SWITCH VARIANT ANTIBODY IGG2A(S) CRYSTALLIZED AT PH 6.75	0.115	26	22	1	26	1	26	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	3ezj-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3ezj-assembly1.cif.gz_B Crystal structure of the N-terminal domain of the secretin GspD from ETEC determined with the assistance of a nanobody	0.148	27	22	1	27	1	27	6.363E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6zpl-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	6zpl-assembly1.cif.gz_F Inward-open structure of human glycine transporter 1 in complex with a benzoylisoindoline inhibitor, sybody Sb_GlyT1#7 and bound Na and Cl ions.	0.153	26	21	1	26	1	26	6.363E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	3dv6-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3dv6-assembly1.cif.gz_B Crystal structure of SAG506-01, tetragonal, crystal 2	0.133	30	25	1	30	1	30	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kn6-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kn6-assembly1.cif.gz_C Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3	0.137	29	24	1	29	1	29	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	3qxu-assembly4.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3qxu-assembly4.cif.gz_B Free Structure of an Anti-Methotrexate CDR1-3 Graft VHH Antibody	0.153	26	21	1	26	1	26	4.418E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5boz-assembly6.cif.gz_L	LOKIASV2_4415_ESMFold_ribonuclease_HII	5boz-assembly6.cif.gz_L Ricin A chain bound to camelid nanobody (VHH9)(E1)	0.166	24	19	1	24	2	25	3.464E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7m1h-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7m1h-assembly1.cif.gz_E Crystal structure of LC/A-JPU-C10-JPU-D12-JPU-B8-JPU-G3-ciA-F12-ciA-D12	0.153	26	21	1	26	3	28	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7a50-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7a50-assembly1.cif.gz_C Crystal structure of the APH coiled-coil in complex with nanobody Nb26	0.115	26	22	1	26	1	26	4.418E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8hbv-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8hbv-assembly1.cif.gz_B Structure of human UCP1 in the nucleotide-free state	0.133	30	25	1	30	1	30	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7x2m-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7x2m-assembly1.cif.gz_B Crystal structure of nanobody 1-2C7 with SARS-CoV-2 RBD	0.166	30	24	1	30	1	30	4.418E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6yo6-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6yo6-assembly1.cif.gz_C Structure of iC3b1	0.153	26	21	1	26	1	26	4.157E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8hbj-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	8hbj-assembly1.cif.gz_F cocktail of FMDV (A/TUR/14/98) in complex with M678F and M688F	0.153	26	21	1	26	1	26	4.418E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8j9k-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8j9k-assembly1.cif.gz_D Structure of basal beta-arrestin2	0.133	30	25	1	30	2	31	4.157E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7nkt-assembly1.cif.gz_BBB	LOKIASV2_4415_ESMFold_ribonuclease_HII	7nkt-assembly1.cif.gz_BBB RBD domain of SARS-CoV2 in complex with neutralizing nanobody NM1226	0.133	30	25	1	30	1	30	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7oay-assembly1.cif.gz_BBB	LOKIASV2_4415_ESMFold_ribonuclease_HII	7oay-assembly1.cif.gz_BBB Nanobody F2 bound to RBD	0.137	29	24	1	29	1	29	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7r63-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7r63-assembly2.cif.gz_B Nb82, a nanobody against voltage gated sodium channels Nav1.4 and Nav1.5	0.133	30	25	1	30	1	30	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7x8y-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7x8y-assembly1.cif.gz_H The SARS-CoV-2 receptor binding domain bound with the Fab fragment of a human neutralizing antibody Ab159	0.166	24	19	1	24	1	24	3.912E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7xl1-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7xl1-assembly2.cif.gz_B Crystal structure of chimeric 7D12-Vob nanobody at 1.65 Angstrom	0.153	26	21	1	26	1	26	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zr7-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zr7-assembly1.cif.gz_F OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN	0.100	30	26	1	30	1	30	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8dao-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	8dao-assembly2.cif.gz_A Crystal structure of SARS-CoV-2 spike stem fusion peptide in complex with neutralizing antibody COV44-79	0.096	31	27	1	31	1	31	4.989E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5n88-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5n88-assembly2.cif.gz_A Crystal structure of antibody bound to viral protein	0.129	31	26	1	31	1	31	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	3stb-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3stb-assembly1.cif.gz_B A complex of two editosome proteins and two nanobodies	0.153	26	21	1	26	1	26	4.418E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7anq-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7anq-assembly1.cif.gz_B Complete PCSK9 C-ter domain in complex with VHH P1.40	0.200	30	22	1	30	1	29	3.464E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cyc-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cyc-assembly1.cif.gz_E SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34	0.137	29	24	1	29	1	29	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cyj-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cyj-assembly1.cif.gz_D RBD of SARS-CoV-2 Spike protein in complex with pan-sarbecovirus nanobodies 2-10, 2-67, 2-62 and 1-25	0.137	29	24	1	29	1	29	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8emz-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8emz-assembly1.cif.gz_B Structure of GII.17 norovirus in complex with Nanobody 2	0.153	26	21	1	26	1	26	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	4i1n-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4i1n-assembly1.cif.gz_B R104A-ca1697 nanobody binding to the binary DHFR.folate complex	0.115	26	22	1	26	1	26	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7km6-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7km6-assembly1.cif.gz_H APOBEC3B antibody 5G7 Fv-clasp	0.115	26	22	1	26	1	26	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7xsb-assembly4.cif.gz_J	LOKIASV2_4415_ESMFold_ribonuclease_HII	7xsb-assembly4.cif.gz_J Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-3B11 Fab	0.166	30	24	1	30	1	30	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly1.cif.gz_H Fab fragment of anti-cocaine antibody h2E2 bound to benzoylecgonine	0.153	26	21	1	26	1	26	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8ee1-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8ee1-assembly1.cif.gz_B KS-AT didomain from module 2 of the 6-deoxyerythronolide B synthase in complex with antibody fragment AA5	0.137	29	24	1	29	1	29	6.363E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ct7-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ct7-assembly1.cif.gz_H Fab of anti-a-synuclein antibody BIIB054 in complex with acetylated a-synuclein peptide (1-10)	0.166	30	24	1	30	1	30	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6wtv-assembly4.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	6wtv-assembly4.cif.gz_E Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 258259	0.129	31	26	1	31	1	31	5.988E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5t33-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5t33-assembly1.cif.gz_H Crystal structure of strain-specific glycan-dependent CD4 binding site-directed neutralizing antibody CAP257-RH1, in complex with HIV-1 strain RHPA gp120 core with an oligomannose N276 glycan.	0.137	29	24	1	29	1	29	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6bft-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6bft-assembly1.cif.gz_A Structure of Bevacizumab Fab mutant in complex with VEGF	0.166	30	24	1	30	1	30	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	5gzn-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5gzn-assembly1.cif.gz_H Structure of neutralizing antibody bound to Zika envelope protein	0.103	29	25	1	29	1	29	5.302E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	8axh-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8axh-assembly1.cif.gz_H Crystal structure of a MUC1-like glycopeptide containing the unnatural L-4-hydroxynorvaline in complex with scFv-SM3	0.133	30	25	1	30	1	30	4.989E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ca6-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ca6-assembly1.cif.gz_H Crystal structure of PCT64_35S, a broadly neutralizing anti-HIV antibody.	0.166	30	24	1	30	1	30	4.695E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	4cau-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	4cau-assembly1.cif.gz_D THREE-DIMENSIONAL STRUCTURE OF DENGUE VIRUS SEROTYPE 1 COMPLEXED WITH 2 HMAB 14C10 FAB	0.115	26	22	1	26	1	26	5.635E+00	20
LOKIASV2_4415_ESMFold_ribonuclease_HII	7n9v-assembly1.cif.gz_J	LOKIASV2_4415_ESMFold_ribonuclease_HII	7n9v-assembly1.cif.gz_J CA-targeting nanobody is a tool for studying HIV-1 capsid lattice interactions	0.133	30	25	1	30	1	30	4.989E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	1a7n-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1a7n-assembly1.cif.gz_H FV FRAGMENT OF MOUSE MONOCLONAL ANTIBODY D1.3 (BALB/C, IGG1, K) VARIANT FOR CHAIN L GLU81->ASP AND CHAIN H LEU312->VAL	0.185	26	20	1	26	1	26	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8et0-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8et0-assembly1.cif.gz_C Crystal Complex of murine Cyclooxygenase-2 with alpaca nanobody F9	0.142	28	23	1	28	1	28	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8fxv-assembly1.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	8fxv-assembly1.cif.gz_B-2 Crystal structure of human proTGF-beta2 in complex with Nb18	0.153	26	21	1	26	1	26	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4m3j-assembly3.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4m3j-assembly3.cif.gz_A Structure of a single-domain camelid antibody fragment cAb-H7S specific of the BlaP beta-lactamase from Bacillus licheniformis	0.148	27	22	1	27	1	27	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5o05-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5o05-assembly1.cif.gz_C GII.10 Vietnam 026 norovirus protruding domain in complex with Nanobody Nano-42	0.148	27	22	1	27	1	27	8.116E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	1t2j-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	1t2j-assembly1.cif.gz_A Crystal structure of a Human VH domain	0.153	26	21	1	26	1	26	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6u02-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6u02-assembly1.cif.gz_H CryoEM-derived model of NA-63 Fab in complex with N9 Shanghai2	0.137	29	24	1	29	1	29	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kji-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kji-assembly1.cif.gz_A Plasmodium falciparum protein Pf12p bound to nanobody D9	0.153	26	21	1	26	1	26	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7txz-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7txz-assembly1.cif.gz_H Nipah Virus attachment (G) glycoprotein ectodomain in complex with nAH1.3 neutralizing antibody Fab fragment (local refinement of the distal region)	0.133	30	25	1	30	1	30	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	3dv4-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3dv4-assembly1.cif.gz_B Crystal structure of SAG506-01, tetragonal, crystal 1	0.161	30	24	1	30	1	30	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sak-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sak-assembly1.cif.gz_B Crystal Structure of LaM4 Nanobody bound to mCherry	0.103	29	25	1	29	1	29	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7unz-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7unz-assembly2.cif.gz_A Crystal structure of H2 nanobody in complex with PfCSS	0.137	29	24	1	29	1	29	7.637E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	3zhd-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3zhd-assembly1.cif.gz_B The crystal structure of single domain antibody 8-4 scaffold.	0.153	26	21	1	26	1	26	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8eln-assembly2.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	8eln-assembly2.cif.gz_G Crystal Structure of Nanobody VHH222 Bound to Its Antigen PA14 Cif	0.133	30	25	1	30	3	32	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en6-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en6-assembly1.cif.gz_D Structure of GII.4 norovirus in complex with Nanobody 76	0.137	29	24	1	29	1	29	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5f7l-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5f7l-assembly1.cif.gz_B Blood group antigen binding adhesin BabA of Helicobacter pylori strain 17875 in complex with Nanobody Nb-ER14	0.148	27	22	1	27	1	27	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7n8h-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7n8h-assembly1.cif.gz_C SARS-CoV-2 S (B.1.429 / epsilon variant) + S2M11 + S2L20 Global Refinement	0.137	29	24	1	29	1	29	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7pnm-assembly1.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	7pnm-assembly1.cif.gz_I Human coronavirus OC43 spike glycoprotein ectodomain in complex with the 46C12 antibody Fab fragment	0.103	29	25	1	29	1	29	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7ubx-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7ubx-assembly2.cif.gz_C Structure of a pore forming fragment of Clostridium difficile toxin A in complex with VHH AA6	0.137	29	24	1	29	1	29	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	2uud-assembly2.cif.gz_J	LOKIASV2_4415_ESMFold_ribonuclease_HII	2uud-assembly2.cif.gz_J Crystal structure of the TEPC15-Vk45.1 anti-2-phenyl-5-oxazolone NQ10- 1.12 scFv in complex with the hapten	0.133	30	25	1	30	1	30	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zkw-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zkw-assembly2.cif.gz_D Crystal structure of cystinosin from Arabidopsis thaliana in complex with Cystine and sybody	0.166	30	23	1	30	1	29	4.989E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4hem-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	4hem-assembly1.cif.gz_F Llama vHH-02 binder of ORF49 (RBP) from lactococcal phage TP901-1	0.137	29	24	1	29	1	29	4.695E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8p8j-assembly1.cif.gz_Z	LOKIASV2_4415_ESMFold_ribonuclease_HII	8p8j-assembly1.cif.gz_Z Structure of 5D3-Fab and nanobody(Nb96)-bound ABCG2	0.137	29	24	1	29	1	29	4.418E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4idl-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4idl-assembly1.cif.gz_A Low melting temperature Anti-Cholera Toxin Llama VHH domain	0.148	27	22	1	27	1	27	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4nby-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4nby-assembly1.cif.gz_B Crystal Structure of TcdA-A2 Bound to Two Molecules of A20.1 VHH	0.153	26	21	1	26	1	26	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7aqz-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7aqz-assembly1.cif.gz_C Co-Crystal Structure of Variant Surface Glycoprotein VSG2 in complex with Nanobody VSG2(NB14)	0.166	24	19	1	24	1	24	4.989E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ir1-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ir1-assembly1.cif.gz_B Crystal structure of red fluorescent protein mCherry complexed with the nanobody LaM4 at 1.9 Angstron resolution	0.107	28	24	2	29	3	30	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7a17-assembly3.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	7a17-assembly3.cif.gz_F Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody	0.161	31	24	1	30	1	31	3.912E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	1u0q-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	1u0q-assembly2.cif.gz_B Structure of a Llama VHH domain raised against a carbazole molecule	0.153	26	21	1	26	1	26	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5e7f-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5e7f-assembly1.cif.gz_A Complex between lactococcal phage Tuc2009 RBP head domain and a nanobody (L06)	0.137	29	24	1	29	1	29	7.637E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7bpk-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7bpk-assembly1.cif.gz_H Zika virus envelope protein mutant bound to mAb	0.115	26	22	1	26	1	26	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8itf-assembly1.cif.gz_N	LOKIASV2_4415_ESMFold_ribonuclease_HII	8itf-assembly1.cif.gz_N Cryo-EM structure of the DMCHA-bound mTAAR9-Gs complex	0.137	29	24	1	29	1	29	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7t4r-assembly1.cif.gz_S	LOKIASV2_4415_ESMFold_ribonuclease_HII	7t4r-assembly1.cif.gz_S CryoEM structure of the HCMV Pentamer gH/gL/UL128/UL130/UL131A in complex with THBD and neutralizing fabs MSL-109 and 13H11	0.161	31	25	1	31	1	31	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7wm0-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7wm0-assembly1.cif.gz_H Cryo-EM structure of the Omicron RBD in complex with 35B5 Fab( local refinement of the RBD and 35B5 Fab)	0.103	29	25	1	29	1	29	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5f1o-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5f1o-assembly1.cif.gz_B human CD38 in complex with nanobody MU551	0.137	29	24	1	29	1	29	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4tvs-assembly2.cif.gz_b	LOKIASV2_4415_ESMFold_ribonuclease_HII	4tvs-assembly2.cif.gz_b LAP1(aa356-583), H.sapiens, bound to VHH-BS1	0.137	29	24	1	29	2	30	7.637E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7lzp-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7lzp-assembly1.cif.gz_B LC/A-JPU-B9-JPU-A11-JPU-G11	0.100	30	26	1	30	2	31	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7om5-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7om5-assembly1.cif.gz_A Anti-EGFR nanobody EgB4	0.137	29	24	1	29	1	29	5.302E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5xcu-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	5xcu-assembly2.cif.gz_D Crystal structure of 12CA5 Fv-clasp fragment with its antigen peptide	0.133	30	24	1	30	1	29	4.695E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7pa8-assembly1.cif.gz_LLL	LOKIASV2_4415_ESMFold_ribonuclease_HII	7pa8-assembly1.cif.gz_LLL JC polyomavirus VP1 in complex with Fab 27C2	0.137	29	24	1	29	1	29	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6wtv-assembly2.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6wtv-assembly2.cif.gz_H Plasmodium vivax reticulocyte binding protein 2b (PvRBP2b) bound to human monoclonal antibody 258259	0.129	31	26	1	31	1	31	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4k94-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	4k94-assembly1.cif.gz_H Crystal structure of KIT D4D5 fragment in complex with anti-Kit antibody Fab19	0.129	31	26	1	31	1	31	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	4xi5-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	4xi5-assembly1.cif.gz_D gHgL of varicella-zoster virus in complex with human neutralizing antibodies	0.133	30	24	1	30	1	29	4.418E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7tus-assembly3.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7tus-assembly3.cif.gz_E Sculpting a uniquely reactive cysteine residue for site-specific antibody conjugation	0.137	29	24	1	29	1	29	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5wdf-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5wdf-assembly1.cif.gz_H Crystal structure of 10E8v4-5R+100cF Fab in complex with HIV-1 gp41 peptide	0.166	30	24	1	30	1	30	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6azx-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6azx-assembly2.cif.gz_C Crystal structure of the neutralizing anti-circumsporozoite protein 663 antibody	0.208	24	18	1	24	1	24	5.302E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7rpu-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7rpu-assembly1.cif.gz_A Crystal Structure of Protective Human Antibody 3A6 Fab Against Ebola Virus with GP Stalk/MPER Epitope Peptide	0.153	26	21	1	26	1	26	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	2qsc-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	2qsc-assembly1.cif.gz_H Crystal structure analysis of anti-HIV-1 V3-Fab F425-B4e8 in complex with a V3-peptide	0.172	29	23	1	29	1	29	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7a0w-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7a0w-assembly2.cif.gz_C Structure of dimeric sodium proton antiporter NhaA, at pH 8.5, crystallized with chimeric Fab antibodies	0.137	29	24	1	29	1	29	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6msy-assembly1.cif.gz_H-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	6msy-assembly1.cif.gz_H-2 Anti-HIV-1 Fab Fab 2G12 + Man4 re-refinement	0.153	26	21	1	26	1	26	5.302E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	3oaz-assembly2.cif.gz_M	LOKIASV2_4415_ESMFold_ribonuclease_HII	3oaz-assembly2.cif.gz_M A non-self sugar mimic of the HIV glycan shield shows enhanced antigenicity	0.153	26	21	1	26	1	26	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	3nh7-assembly2.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	3nh7-assembly2.cif.gz_I Crystal structure of the neutralizing Fab fragment AbD1556 bound to the BMP type I receptor IA	0.153	26	21	1	26	1	26	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	2r1x-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	2r1x-assembly1.cif.gz_B Crystal structure of S25-2 Fab in complex with Kdo analogues	0.133	30	25	1	30	1	30	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6bft-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6bft-assembly1.cif.gz_H Structure of Bevacizumab Fab mutant in complex with VEGF	0.166	30	24	1	30	1	30	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7dm2-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7dm2-assembly1.cif.gz_H crystal structure of the M. tuberculosis phosphate ABC transport receptor PstS-1 in complex with Fab p4-170	0.137	29	24	1	29	1	29	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8hes-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8hes-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 RBD and NIV-10 complex	0.133	30	25	1	30	1	30	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	3utz-assembly4.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	3utz-assembly4.cif.gz_B-2 Endogenous-like inhibitory antibodies targeting activated metalloproteinase motifs show therapeutic potential	0.137	29	24	1	29	1	29	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6n2x-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6n2x-assembly1.cif.gz_H Anti-HIV-1 Fab 2G12 + Man9 re-refinement	0.153	26	21	1	26	1	26	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ugs-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ugs-assembly1.cif.gz_H Crystal structure of the Fab fragment of PF06438179/GP1111 an infliximab biosimilar in a C-centered orthorhombic crystal form, Lot A	0.133	30	25	1	30	1	30	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6mhr-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6mhr-assembly2.cif.gz_A Structure of the human 4-1BB / Urelumab Fab complex	0.153	26	21	1	26	1	26	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6was-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6was-assembly1.cif.gz_H Structure of D19.PA8 Fab in complex with 1FD6 16055 V1V2 scaffold	0.153	26	21	1	26	1	26	6.363E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	3nh7-assembly3.cif.gz_J	LOKIASV2_4415_ESMFold_ribonuclease_HII	3nh7-assembly3.cif.gz_J Crystal structure of the neutralizing Fab fragment AbD1556 bound to the BMP type I receptor IA	0.153	26	21	1	26	1	26	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	5u3l-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5u3l-assembly1.cif.gz_H Crystal Structure of DH511.2 Fab in Complex with HIV-1 gp41 MPER 670-683 Peptide	0.153	26	21	1	26	1	26	6.762E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8fdd-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	8fdd-assembly1.cif.gz_A Crystal structure of Ky15.3 Fab in complex with circumsporozoite protein NPDP peptide	0.153	26	21	1	26	1	26	7.187E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6tgg-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6tgg-assembly1.cif.gz_H scFv-1SM3 in complex with glycopeptide containing an sp2-imino sugar	0.133	30	25	1	30	1	30	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	8gb5-assembly3.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	8gb5-assembly3.cif.gz_I Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9	0.133	30	25	1	30	1	30	5.635E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7b17-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7b17-assembly1.cif.gz_B SARS-CoV-spike RBD bound to two neutralising nanobodies.	0.137	29	24	1	29	1	29	7.637E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	6hd8-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6hd8-assembly1.cif.gz_A Crystal structure of the potassium channel MtTMEM175 in complex with a Nanobody-MBP fusion protein	0.133	30	25	1	30	1	30	5.988E+00	19
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sr5-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sr5-assembly2.cif.gz_D Single chain trimer HLA-A*02:01 (Y108C, A163C) with Wilms tumor protein peptide RMFPNAPYL	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5omn-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5omn-assembly1.cif.gz_C GII.10 Vietnam 026 protruding domain in complex with Nanobody Nano-27	0.137	29	24	1	29	1	29	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7czd-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7czd-assembly2.cif.gz_C Crystal structure of PD-L1 in complex with a VHH	0.137	29	24	1	29	1	29	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8q7s-assembly3.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8q7s-assembly3.cif.gz_H Crystal structure of the SARS-CoV-2 RBD (Wuhan) with neutralizing VHHs Ma6F06 and Re21H01	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	2xxc-assembly1.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	2xxc-assembly1.cif.gz_B-2 Crystal structure of a camelid VHH raised against the HIV-1 capsid protein C-terminal domain.	0.166	24	19	1	24	2	25	5.302E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	2ybr-assembly3.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	2ybr-assembly3.cif.gz_G Crystal structure of the human derived single chain antibody fragment (scFv) 9004G in complex with Cn2 toxin from the scorpion Centruroides noxius Hoffmann	0.137	29	24	1	29	1	29	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8be2-assembly1.cif.gz_N	LOKIASV2_4415_ESMFold_ribonuclease_HII	8be2-assembly1.cif.gz_N Crystal structure of SOS1-Nanobody77	0.133	30	25	1	30	1	30	4.989E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6cnv-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6cnv-assembly1.cif.gz_C INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6itc-assembly1.cif.gz_V	LOKIASV2_4415_ESMFold_ribonuclease_HII	6itc-assembly1.cif.gz_V Structure of a substrate engaged SecA-SecY protein translocation machine	0.153	26	21	1	26	1	26	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7tn9-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7tn9-assembly1.cif.gz_A Structure of the Inmazeb cocktail and resistance to escape against Ebola virus	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7ymj-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7ymj-assembly1.cif.gz_D Cryo-EM structure of alpha1AAR-Nb6 complex bound to tamsulosin	0.115	26	22	1	26	1	26	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kd0-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kd0-assembly1.cif.gz_C Ricin bound to VHH antibody V2C11	0.200	29	22	1	29	2	30	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8gnk-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8gnk-assembly1.cif.gz_H CryoEM structure of cytosol-facing, substrate-bound ratGAT1	0.153	26	21	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7km5-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7km5-assembly1.cif.gz_D Crystal structure of SARS-CoV-2 RBD complexed with Nanosota-1	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7upd-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7upd-assembly1.cif.gz_B Prefusion-stabilized Nipah virus fusion protein complexed with Fab 2B12	0.133	30	25	1	30	1	30	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7wur-assembly1.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	7wur-assembly1.cif.gz_G CryoEM structure of sNS1 complexed with Fab5E3	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5xs7-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5xs7-assembly1.cif.gz_H Structure of Coxsackievirus A6 (CVA6) virus A-particle in complex with the neutralizing antibody fragment 1D5	0.153	26	21	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8fis-assembly1.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	8fis-assembly1.cif.gz_I Structure of Bispecific CAP256V2LS-J3 Fab in complex with BG505 DS-SOSIP.664	0.172	29	23	1	29	1	29	9.166E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8r61-assembly4.cif.gz_L	LOKIASV2_4415_ESMFold_ribonuclease_HII	8r61-assembly4.cif.gz_L Structure of IgE delta epsilon 3-4 in complex with a kappa binding nanobody	0.153	26	21	1	26	1	26	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8t03-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8t03-assembly1.cif.gz_C Structure of mouse Myomaker bound to Fab18G7 in detergent	0.160	24	19	1	24	1	24	6.363E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7a4t-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7a4t-assembly1.cif.gz_A Crystal structure of the GCN coiled-coil in complex with nanobody Nb39	0.148	27	22	1	27	1	27	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7aej-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7aej-assembly1.cif.gz_D Crystal structure of asymmetric HIV-1 gp41 containing all membrane anchors	0.128	39	27	1	39	1	32	4.418E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8c5h-assembly1.cif.gz_N	LOKIASV2_4415_ESMFold_ribonuclease_HII	8c5h-assembly1.cif.gz_N NbSyt1 anti-(rat Synaptotagmin-1) nanobody bound to target cytosolic domain of Synaptotagmin-1	0.173	23	18	2	24	5	27	5.302E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	3zhl-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	3zhl-assembly1.cif.gz_A The crystal structure of single domain antibody 8-14 scaffold	0.153	26	21	1	26	1	26	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cxq-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cxq-assembly1.cif.gz_D SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 1-22	0.161	30	24	1	30	1	30	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8emy-assembly1.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	8emy-assembly1.cif.gz_G Structure of GII.4 norovirus in complex with Nanobody 82	0.100	30	26	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5ja9-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5ja9-assembly2.cif.gz_B Crystal structure of the HigB2 toxin in complex with Nb6	0.137	29	24	1	29	1	29	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4udf-assembly1.cif.gz_1D	LOKIASV2_4415_ESMFold_ribonuclease_HII	4udf-assembly1.cif.gz_1D STRUCTURAL BASIS OF HUMAN PARECHOVIRUS NEUTRALIZATION BY HUMAN MONOCLONAL ANTIBODIES	0.137	29	24	1	29	1	29	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7wwl-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7wwl-assembly1.cif.gz_H S protein of Delta variant in complex with ZWD12	0.192	26	20	1	26	1	26	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6z1v-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6z1v-assembly1.cif.gz_B Structure of the EC2 domain of CD9 in complex with nanobody 4E8	0.115	26	22	1	26	1	26	6.363E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8dyt-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	8dyt-assembly1.cif.gz_E Cryo-EM structure of 227 Fab in complex with (NPNA)8 peptide	0.193	31	23	1	31	1	30	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7o06-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7o06-assembly2.cif.gz_B Crystal structure of the N-terminal domain of CEP164(1-109) bound to camelid nanobody 10Z	0.137	29	24	1	29	1	29	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6rtw-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6rtw-assembly1.cif.gz_B Crystal structure of the Patched-1 (PTCH1) ectodomain in complex with nanobody NB64 and cholesterol-hemisuccinate	0.148	27	22	1	27	1	27	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7xli-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7xli-assembly1.cif.gz_B Crystal structure of IsdB linker-NEAT2 bound to a nanobody (VHH)	0.205	34	25	1	34	1	33	5.635E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6do1-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6do1-assembly2.cif.gz_D Structure of nanobody-stabilized angiotensin II type 1 receptor bound to S1I8	0.153	26	21	1	26	1	26	9.740E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8en5-assembly1.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	8en5-assembly1.cif.gz_E Structure of GII.4 norovirus in complex with Nanobody 56	0.115	26	22	1	26	1	26	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4n1h-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	4n1h-assembly2.cif.gz_D Structure of a single-domain camelid antibody fragment cAb-F11N in complex with the BlaP beta-lactamase from Bacillus licheniformis	0.133	30	24	1	30	1	29	4.989E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8dqu-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	8dqu-assembly1.cif.gz_A Nanobody bound SARS-CoV-2 Nsp9	0.153	26	21	1	26	2	27	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5thr-assembly1.cif.gz_M	LOKIASV2_4415_ESMFold_ribonuclease_HII	5thr-assembly1.cif.gz_M Cryo-EM structure of a BG505 Env-sCD4-17b-8ANC195 complex	0.100	30	26	1	30	1	30	5.988E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6f2w-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6f2w-assembly1.cif.gz_B Bacterial asc transporter crystal structure in open to in conformation	0.148	27	22	1	27	1	27	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6z10-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6z10-assembly1.cif.gz_B Crystal structure of a humanized (K18E, K269N) rat succinate receptor SUCNR1 (GPR91) in complex with a nanobody and antagonist	0.133	30	25	1	30	1	30	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7eo0-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7eo0-assembly1.cif.gz_H FOOT AND MOUTH DISEASE VIRUS O/TIBET/99-BOUND THE SINGLE CHAIN FRAGMEN ANTIBODY C4	0.076	26	23	1	26	1	26	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6rnk-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6rnk-assembly1.cif.gz_B Crystal structure of a humanized (K18E, K269N) rat succinate receptor SUCNR1 (GPR91) in complex with a nanobody and antagonist NF-56-EJ40.	0.153	26	21	1	26	1	26	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7swp-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7swp-assembly1.cif.gz_H G32Q4 Fab in complex with SARS-CoV-2 Spike 6P (RBD local reconstruction)	0.115	26	22	1	26	1	26	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4w70-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4w70-assembly1.cif.gz_A Periplasmically Produced Monomeric Single Domain Antibody (sdAb) C22A/C99V variant against Staphylococcal enterotoxin B (SEB) at pH 7.0	0.083	24	21	1	24	2	25	6.363E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5gxb-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5gxb-assembly1.cif.gz_B crystal structure of a LacY/Nanobody complex	0.083	24	21	1	24	2	25	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5xcu-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5xcu-assembly1.cif.gz_A Crystal structure of 12CA5 Fv-clasp fragment with its antigen peptide	0.115	26	22	1	26	1	26	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7pa8-assembly1.cif.gz_JJJ	LOKIASV2_4415_ESMFold_ribonuclease_HII	7pa8-assembly1.cif.gz_JJJ JC polyomavirus VP1 in complex with Fab 27C2	0.137	29	24	1	29	1	29	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8as0-assembly7.cif.gz_W	LOKIASV2_4415_ESMFold_ribonuclease_HII	8as0-assembly7.cif.gz_W PD-1 extracellular domain in complex with Fab fragment from D12 antibody	0.153	26	21	1	26	1	26	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6bhz-assembly2.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	6bhz-assembly2.cif.gz_I Trastuzumab Fab D185A (Light Chain) Mutant.	0.129	31	26	1	31	1	31	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly2.cif.gz_B Fab fragment of anti-cocaine antibody h2E2 bound to benzoylecgonine	0.153	26	21	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7e9b-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7e9b-assembly1.cif.gz_H Structural basis of HLX10 PD-1 receptor recognition, a promising anti-PD-1 antibody clinical candidate for cancer immunotherapy	0.153	26	21	1	26	1	26	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4nhh-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	4nhh-assembly1.cif.gz_H Structure of 2G12 IgG Dimer	0.153	26	21	1	26	1	26	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6rm3-assembly1.cif.gz_SB0	LOKIASV2_4415_ESMFold_ribonuclease_HII	6rm3-assembly1.cif.gz_SB0 Evolutionary compaction and adaptation visualized by the structure of the dormant microsporidian ribosome	0.070	97	62	1	68	107	203	3.260E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5ijk-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5ijk-assembly2.cif.gz_B Crystal structure of anti-gliadin 1002-1E03 Fab fragment in complex of peptide PLQPEQPFP	0.133	30	25	1	30	1	30	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	3i02-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	3i02-assembly2.cif.gz_D Crystal structure of S54-10 antibody in complex with antigen Kdo(2.4)Kdo(2.4)Kdo	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kn6-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kn6-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain complexed with nanobody VHH V and antibody Fab CC12.3	0.137	29	24	1	29	1	29	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7rth-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7rth-assembly1.cif.gz_B Crystal structure of an anti-lysozyme nanobody in complex with an anti-nanobody Fab "NabFab"	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4hgw-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4hgw-assembly1.cif.gz_B Crystal structure of S25-2 in complex with a 5,6-dehydro-Kdo disaccharide	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	3utz-assembly4.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	3utz-assembly4.cif.gz_F Endogenous-like inhibitory antibodies targeting activated metalloproteinase motifs show therapeutic potential	0.137	29	24	1	29	1	29	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8d7e-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	8d7e-assembly1.cif.gz_D Cryo-EM structure of human CNTFR alpha in complex with the Fab fragments of two antibodies	0.076	26	23	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	3eo9-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	3eo9-assembly1.cif.gz_H Crystal structure the Fab fragment of Efalizumab	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly8.cif.gz_N	LOKIASV2_4415_ESMFold_ribonuclease_HII	6nfn-assembly8.cif.gz_N Fab fragment of anti-cocaine antibody h2E2 bound to benzoylecgonine	0.153	26	21	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5x8m-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5x8m-assembly1.cif.gz_B PD-L1 in complex with durvalumab	0.153	26	21	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5ifj-assembly3.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	5ifj-assembly3.cif.gz_G Crystal structure of anti-gliadin 1002-1E01 Fab fragment in complex of peptide PLQPEQPFP	0.137	29	24	1	29	1	29	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5mv3-assembly3.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	5mv3-assembly3.cif.gz_F ACC1 Fab fragment in complex with CII583-591 (CG10)	0.103	29	25	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7rxi-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7rxi-assembly1.cif.gz_H Fab234 in complex with the C-terminal alpha-TSR domain of P. falciparum	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6n81-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6n81-assembly1.cif.gz_C Crystal structure of GII.4 2002 norovirus P domain in complex with cross-reactive human antibody A1227	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7t86-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7t86-assembly1.cif.gz_H Crystal Structure of Fab CR5133 / Phospho-SD Peptide Complex	0.137	29	24	1	29	1	29	9.166E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	1bj1-assembly1.cif.gz_K	LOKIASV2_4415_ESMFold_ribonuclease_HII	1bj1-assembly1.cif.gz_K VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6p95-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	6p95-assembly1.cif.gz_F Structure of Lassa virus glycoprotein in complex with Fab 25.6A	0.133	30	25	1	30	1	30	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7tp4-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7tp4-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22	0.192	26	20	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	2v7h-assembly2.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	2v7h-assembly2.cif.gz_H Crystal structure of an immunogen specific anti-mannopyranoside monoclonal antibody Fab fragment	0.096	31	27	1	31	1	31	9.740E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7mf9-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7mf9-assembly2.cif.gz_C Crystal structure of antibody 10E8v4-P100fA Fab in space group C2	0.166	30	24	1	30	1	30	6.363E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	3g6a-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3g6a-assembly2.cif.gz_B Crystal structure of anti-IL-13 antibody CNTO607	0.137	29	24	1	29	1	29	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	2r23-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	2r23-assembly1.cif.gz_B Crystal structure of S25-2 Fab in complex with Kdo analogues	0.133	30	25	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5u3k-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5u3k-assembly1.cif.gz_H Crystal Structure of DH511.2 Fab in Complex with HIV-1 gp41 MPER 662-683 Peptide	0.153	26	21	1	26	1	26	9.166E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4q2z-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	4q2z-assembly2.cif.gz_A Fab fragment of HIV vaccine-elicited CD4bs-directed antibody, GE356, from a non-human primate	0.066	30	27	1	30	1	30	8.625E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	4f57-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	4f57-assembly1.cif.gz_H Fab structure of a neutralizing antibody L1 from an early subtype A HIV-1 infected patient	0.172	29	23	1	29	1	29	9.166E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7wo7-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7wo7-assembly1.cif.gz_A Locally refined region of SARS-CoV-2 Spike in complex with IgG 553-15	0.133	30	25	1	30	1	30	6.762E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ehx-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ehx-assembly1.cif.gz_B scFv AbVance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery	0.100	30	26	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6kr0-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6kr0-assembly1.cif.gz_A Crystal structure of HL homo-diabody	0.133	30	25	1	30	1	30	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	7s0j-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7s0j-assembly1.cif.gz_H Crystal structure of Epstein-Barr virus gH/gL targeting antibody 769B10	0.133	30	25	1	30	1	30	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	5b3n-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5b3n-assembly1.cif.gz_A The crystal structure of anti-H4K20me1_scFv, 15F11	0.153	26	21	1	26	1	26	7.187E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	6qf9-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6qf9-assembly1.cif.gz_A Structure of an anti-Mcl1 scFv	0.153	26	21	1	26	1	26	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8dy0-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8dy0-assembly2.cif.gz_B Crystal Structure of spFv GLK1 HL	0.153	26	21	1	26	1	26	8.116E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	8g8w-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8g8w-assembly1.cif.gz_B Molecular mechanism of nucleotide inhibition of human uncoupling protein 1	0.100	30	26	1	30	1	30	7.637E+00	18
LOKIASV2_4415_ESMFold_ribonuclease_HII	1dl7-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1dl7-assembly1.cif.gz_H THE STRUCTURAL BASIS OF REPERTOIRE SHIFT IN AN IMMUNE RESPONSE TO PHOSPHOCHOLINE	0.166	24	19	1	24	1	24	7.187E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sr5-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sr5-assembly1.cif.gz_B Single chain trimer HLA-A*02:01 (Y108C, A163C) with Wilms tumor protein peptide RMFPNAPYL	0.137	29	24	1	29	1	29	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7mfu-assembly2.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7mfu-assembly2.cif.gz_E Crystal structure of synthetic nanobody (Sb14+Sb68) complexes with SARS-CoV-2 receptor binding domain	0.153	26	21	1	26	1	26	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7jvb-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7jvb-assembly2.cif.gz_D Crystal structure of the SARS-CoV-2 spike receptor-binding domain (RBD) with nanobody Nb20	0.153	26	21	1	26	1	26	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6o28-assembly1.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	6o28-assembly1.cif.gz_G Crystal structure of 4493 Fab in complex with circumsporozoite protein KQPA and anti-kappa VHH domain	0.125	24	20	1	24	1	24	7.187E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6xw7-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6xw7-assembly1.cif.gz_C Crystal structure of murine norovirus P domain in complex with Nanobody NB-5829 and glycochenodeoxycholate (GCDCA)	0.166	24	19	1	24	1	24	7.637E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8sbb-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8sbb-assembly1.cif.gz_B Cryo-EM structure of FtAlkB	0.153	26	21	1	26	1	26	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	1fgv-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1fgv-assembly1.cif.gz_H X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65	0.133	30	25	1	30	1	30	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8cy7-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	8cy7-assembly1.cif.gz_F SARS-CoV-2 Spike protein in complex with a pan-sarbecovirus nanobody 2-34	0.133	30	25	1	30	1	30	6.363E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8hpj-assembly2.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	8hpj-assembly2.cif.gz_E Crystal structure of the bacterial oxalate transporter OxlT in a ligand-free outward-facing form	0.153	26	21	1	26	2	27	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7zkz-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7zkz-assembly1.cif.gz_C Crystal structure of cystinosin from Arabidopsis thaliana bound to two nanobodies	0.148	27	22	1	27	1	27	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	4uu9-assembly2.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	4uu9-assembly2.cif.gz_H Crystal structure of the human c5a in complex with MEDI7814 a neutralising antibody	0.137	29	24	1	29	1	29	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8def-assembly1.cif.gz_U	LOKIASV2_4415_ESMFold_ribonuclease_HII	8def-assembly1.cif.gz_U Cryo-EM Structure of Western Equine Encephalitis Virus VLP in complex with SKW24 fab	0.166	30	24	1	30	1	30	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ysq-assembly2.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ysq-assembly2.cif.gz_H The hC4Nb8 complement inhibitory nanobody in complex with C4b	0.107	28	24	1	28	1	28	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7qsp-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7qsp-assembly1.cif.gz_B Permutated C-terminal lobe of the ribose binding protein from Thermotoga maritima	0.107	82	68	89	170	49	125	7.637E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	2a9m-assembly2.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	2a9m-assembly2.cif.gz_I Structural Analysis of a Tight-binding Fluorescein-scFv; apo form	0.133	30	24	1	30	1	29	6.762E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8elo-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8elo-assembly1.cif.gz_B Crystal structure of SARS-CoV-2 spike protein receptor-binding domain in complex with antibody CC12.1 Fab and nanobody Nb-C4-225	0.137	29	24	1	29	1	29	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8ez7-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8ez7-assembly1.cif.gz_H Structure of 1F04 Fab in complex with A/Moscow/10/1999 (H3N2) influenza virus neuraminidase	0.172	29	23	1	29	1	29	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7lxz-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7lxz-assembly1.cif.gz_H SARS-CoV-2 S/S2M11/S2L28 Global Refinement	0.137	29	24	1	29	1	29	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8ded-assembly1.cif.gz_U	LOKIASV2_4415_ESMFold_ribonuclease_HII	8ded-assembly1.cif.gz_U Cryo-EM Structure of Western Equine Encephalitis Virus VLP in complex with SKW19 fab	0.137	29	24	1	29	1	29	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7fat-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7fat-assembly1.cif.gz_B Structure Determination of the RBD-NB1A7	0.129	31	25	1	30	1	31	5.302E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6uye-assembly1.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	6uye-assembly1.cif.gz_G EBOV GPdMuc Makona bound to rEBOV-548 Fab	0.153	26	21	1	26	1	26	7.637E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	4lmq-assembly2.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	4lmq-assembly2.cif.gz_E Development and Preclinical Characterization of a Humanized Antibody Targeting CXCL12	0.133	30	25	1	30	1	30	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5feh-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5feh-assembly1.cif.gz_B Crystal structure of PCT64_35B, a broadly neutralizing anti-HIV antibody	0.208	24	18	1	24	1	24	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7xsb-assembly2.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	7xsb-assembly2.cif.gz_G Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-3B11 Fab	0.166	30	24	1	30	1	30	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5wob-assembly4.cif.gz_U	LOKIASV2_4415_ESMFold_ribonuclease_HII	5wob-assembly4.cif.gz_U Crystal Structure Analysis of Fab1-Bound Human Insulin Degrading Enzyme (IDE) in Complex with Insulin	0.153	26	21	1	26	1	26	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7xsb-assembly3.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7xsb-assembly3.cif.gz_D Crystal structure of SARS-CoV-2 spike receptor binding domain bound with P5S-3B11 Fab	0.166	30	24	1	30	1	30	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	4nhh-assembly1.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	4nhh-assembly1.cif.gz_I Structure of 2G12 IgG Dimer	0.153	26	21	1	26	1	26	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ct7-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ct7-assembly2.cif.gz_A Fab of anti-a-synuclein antibody BIIB054 in complex with acetylated a-synuclein peptide (1-10)	0.166	30	24	1	30	1	30	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7dc8-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7dc8-assembly1.cif.gz_B Crystal structure of Switch Ab Fab and hIL6R in complex with ATP	0.103	29	25	1	29	1	29	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7dc8-assembly2.cif.gz_E	LOKIASV2_4415_ESMFold_ribonuclease_HII	7dc8-assembly2.cif.gz_E Crystal structure of Switch Ab Fab and hIL6R in complex with ATP	0.103	29	25	1	29	1	29	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6mv5-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6mv5-assembly1.cif.gz_H Anti-PCSK9 fab 6E2 bound to the N-terminal peptide from PCSK9 (E32K)	0.133	30	25	1	30	1	30	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7f3q-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7f3q-assembly1.cif.gz_H SARS-CoV-2 RBD in complex with A5-10 Fab and A34-2 Fab	0.100	30	26	1	30	1	30	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6bi2-assembly2.cif.gz_I	LOKIASV2_4415_ESMFold_ribonuclease_HII	6bi2-assembly2.cif.gz_I Trastuzumab Fab D185A (Light Chain) Mutant Biotin Conjugation.	0.166	24	19	1	24	1	24	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kq7-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kq7-assembly1.cif.gz_H Crystal structure of IL21R in complex with an antibody Fab fragment	0.096	31	27	1	31	1	31	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5uea-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5uea-assembly1.cif.gz_A Structure of antigen-Fab complex with Histone chaperone ASF1	0.133	30	25	1	30	1	30	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5bk5-assembly4.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	5bk5-assembly4.cif.gz_F Crystal structure of the anti-circumsporozoite protein 663 germline antibody	0.133	30	25	1	30	1	30	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6tco-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6tco-assembly2.cif.gz_B Crystal structure of the omalizumab Fab Leu158Pro light chain mutant - crystal form I	0.133	30	25	1	30	1	30	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6d11-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6d11-assembly1.cif.gz_A Crystal structure of 1450 Fab in complex with circumsporozoite protein NANP5	0.153	26	21	1	26	1	26	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6wgj-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6wgj-assembly1.cif.gz_A Fab portion of dupilumab with Crystal Kappa design and no interchain disulfide	0.137	29	24	1	29	1	29	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7c01-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7c01-assembly2.cif.gz_C Molecular basis for a potent human neutralizing antibody targeting SARS-CoV-2 RBD	0.153	26	21	1	26	1	26	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	1mhp-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1mhp-assembly1.cif.gz_H Crystal structure of a chimeric alpha1 integrin I-domain in complex with the Fab fragment of a humanized neutralizing antibody	0.137	29	24	1	29	1	29	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	1ucb-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1ucb-assembly1.cif.gz_H STRUCTURE OF UNCOMPLEXED FAB COMPARED TO COMPLEX (1CLY, 1CLZ)	0.192	26	20	1	26	1	26	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sk5-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sk5-assembly1.cif.gz_F Cryo-EM structure of ACKR3 in complex with CXCL12 and an intracellular Fab	0.133	30	25	1	30	1	30	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	1tzi-assembly1.cif.gz_B-2	LOKIASV2_4415_ESMFold_ribonuclease_HII	1tzi-assembly1.cif.gz_B-2 Crystal Structure of the Fab YADS2 Complexed with h-VEGF	0.153	26	21	1	26	1	26	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5gzn-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	5gzn-assembly2.cif.gz_C Structure of neutralizing antibody bound to Zika envelope protein	0.103	29	25	1	29	1	29	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7mf9-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7mf9-assembly1.cif.gz_H Crystal structure of antibody 10E8v4-P100fA Fab in space group C2	0.166	30	24	1	30	1	30	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7uvo-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	7uvo-assembly1.cif.gz_A Pfs230 domain 1 bound by RUPA-38 Fab	0.115	26	22	1	26	1	26	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6mts-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6mts-assembly1.cif.gz_H Crystal structure of VRC43.03 Fab	0.166	24	19	1	24	1	24	7.637E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6pk8-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6pk8-assembly2.cif.gz_D Antibody scFv-M204 dimeric state	0.222	26	19	1	26	1	26	8.116E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6w00-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	6w00-assembly1.cif.gz_H Crystal structure of Fab239 in complex with NPNA2 peptide from circumsporozoite protein	0.133	30	24	1	30	1	29	7.637E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	8ol9-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8ol9-assembly1.cif.gz_B Anti-FIXa Fab in complex with human des-(Gla-EGF1) FIXa	0.115	26	22	1	26	1	26	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7rth-assembly3.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7rth-assembly3.cif.gz_H Crystal structure of an anti-lysozyme nanobody in complex with an anti-nanobody Fab "NabFab"	0.133	30	25	1	30	1	30	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7y3o-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	7y3o-assembly1.cif.gz_H Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody BIOLS56	0.153	26	21	1	26	1	26	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5iq9-assembly2.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5iq9-assembly2.cif.gz_H Crystal structure of 10E8v4 Fab in complex with an HIV-1 gp41 peptide.	0.166	30	24	1	30	1	30	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7dpm-assembly3.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	7dpm-assembly3.cif.gz_G Crystal structure of SARS-CoV-2 Spike RBD in complex with MW06 Fab	0.137	29	24	1	29	1	29	9.740E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5u4r-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5u4r-assembly1.cif.gz_A Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 53-1A09 Fab.	0.129	31	26	1	31	1	31	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5jny-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5jny-assembly1.cif.gz_A Crystal Structure of 10E8 Fab	0.166	30	24	1	30	1	30	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	5u3m-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	5u3m-assembly1.cif.gz_H Crystal Structure of DH511.11P Fab in Complex with HIV-1 gp41 MPER Peptide	0.172	29	23	1	29	1	29	8.625E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6qf9-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	6qf9-assembly2.cif.gz_B Structure of an anti-Mcl1 scFv	0.137	29	24	1	29	1	29	9.166E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	7u05-assembly1.cif.gz_b	LOKIASV2_4415_ESMFold_ribonuclease_HII	7u05-assembly1.cif.gz_b Structure of the yeast TRAPPII-Rab11/Ypt32 complex in the closed/closed state (composite structure)	0.041	24	22	2	25	706	729	5.988E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	4f1n-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	4f1n-assembly2.cif.gz_B Crystal structure of Kluyveromyces polysporus Argonaute with a guide RNA	0.104	125	92	1	125	580	683	4.695E+00	17
LOKIASV2_4415_ESMFold_ribonuclease_HII	6ck8-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6ck8-assembly1.cif.gz_A Crystal structure of anti-influenza single-domain llama antibody SD38	0.133	30	25	1	30	1	30	9.740E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	7kfb-assembly1.cif.gz_G	LOKIASV2_4415_ESMFold_ribonuclease_HII	7kfb-assembly1.cif.gz_G Ebola virus GP (mucin deleted, Makona strain) bound to antibody Fab EBOV-442	0.166	24	19	1	24	1	24	7.187E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	7e7e-assembly2.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	7e7e-assembly2.cif.gz_C The co-crystal structure of ACE2 with Fab	0.137	29	24	1	29	1	29	9.740E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	5tdo-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	5tdo-assembly1.cif.gz_B Crystal structure of the Fab fragment of anti-HER2 antibody 4D5 with redesigned heavy and light chain interfaces	0.166	24	19	1	24	1	24	9.740E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	1t2q-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	1t2q-assembly1.cif.gz_H The Crystal Structure of an NNA7 Fab that recognizes an N-type blood group antigen	0.208	24	18	1	24	2	25	9.740E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	6kr0-assembly2.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6kr0-assembly2.cif.gz_D Crystal structure of HL homo-diabody	0.133	30	25	1	30	1	30	9.740E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	6psc-assembly3.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	6psc-assembly3.cif.gz_C Antibody scFv-M204 trimeric state	0.222	26	19	1	26	1	26	9.740E+00	16
LOKIASV2_4415_ESMFold_ribonuclease_HII	5wcc-assembly2.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	5wcc-assembly2.cif.gz_A Crystal structure of the broadly neutralizing Influenza A antibody VRC 315 02-1F07 Fab.	0.185	27	20	1	27	1	26	9.740E+00	15
LOKIASV2_4415_ESMFold_ribonuclease_HII	8p4d-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8p4d-assembly1.cif.gz_C Structural insights into human co-transcriptional capping - structure 4	0.027	36	32	4	39	6	39	9.740E+00	14
LOKIASV2_4415_ESMFold_ribonuclease_HII	8hyj-assembly1.cif.gz_C	LOKIASV2_4415_ESMFold_ribonuclease_HII	8hyj-assembly1.cif.gz_C A cryo-EM structure of KTF1-bound polymerase V transcription elongation complex	0.048	41	36	1	41	3	41	9.740E+00	14
LOKIASV2_4415_ESMFold_ribonuclease_HII	8iv5-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	8iv5-assembly1.cif.gz_H Cryo-EM structure of SARS-CoV-2 spike protein in complex with double nAbs 8H12 and 1C4 (local refinement)	0.240	25	17	4	26	2	26	3.681E+00	13
LOKIASV2_4415_ESMFold_ribonuclease_HII	8de6-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	8de6-assembly1.cif.gz_B Oligomeric C9 in complex with aE11 Fab	0.241	29	20	4	30	2	30	4.157E+00	13
LOKIASV2_4415_ESMFold_ribonuclease_HII	5mv3-assembly8.cif.gz_U	LOKIASV2_4415_ESMFold_ribonuclease_HII	5mv3-assembly8.cif.gz_U ACC1 Fab fragment in complex with CII583-591 (CG10)	0.214	28	20	4	29	2	29	4.695E+00	12
LOKIASV2_4415_ESMFold_ribonuclease_HII	7e3b-assembly1.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	7e3b-assembly1.cif.gz_B SARS-Cov-2 spike in complex with the Ab5 neutralizing antibody (focused refinement on Fab-RBD)	0.233	29	20	4	30	2	30	6.363E+00	11
LOKIASV2_4415_ESMFold_ribonuclease_HII	8wc6-assembly1.cif.gz_N	LOKIASV2_4415_ESMFold_ribonuclease_HII	8wc6-assembly1.cif.gz_N Cryo-EM structure of the PEA-bound mTAAR1-Gs complex	0.230	26	19	4	29	2	27	6.762E+00	11
LOKIASV2_4415_ESMFold_ribonuclease_HII	6tou-assembly1.cif.gz_A	LOKIASV2_4415_ESMFold_ribonuclease_HII	6tou-assembly1.cif.gz_A Rabies virus glycoprotein PH domain in complex with the scFv fragment of broadly neutralizing human antibody RVC20	0.233	29	20	4	30	2	30	6.363E+00	11
LOKIASV2_4415_ESMFold_ribonuclease_HII	5nbm-assembly1.cif.gz_F	LOKIASV2_4415_ESMFold_ribonuclease_HII	5nbm-assembly1.cif.gz_F Crystal structure of the Arp4-N-actin(ATP-state) heterodimer bound by a nanobody	0.241	29	20	4	30	2	30	8.625E+00	10
LOKIASV2_4415_ESMFold_ribonuclease_HII	6oro-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	6oro-assembly1.cif.gz_D Modified BG505 SOSIP-based immunogen RC1 in complex with the elicited V3-glycan patch antibody Ab874NHP	0.260	23	15	4	24	2	24	8.625E+00	10
LOKIASV2_4415_ESMFold_ribonuclease_HII	7sk4-assembly1.cif.gz_D	LOKIASV2_4415_ESMFold_ribonuclease_HII	7sk4-assembly1.cif.gz_D Cryo-EM structure of ACKR3 in complex with chemokine N-terminal mutant CXCL12_LRHQ, an intracellular Fab, and an extracellular Fab	0.266	29	19	4	30	2	30	7.637E+00	10
LOKIASV2_4415_ESMFold_ribonuclease_HII	2aep-assembly1.cif.gz_H	LOKIASV2_4415_ESMFold_ribonuclease_HII	2aep-assembly1.cif.gz_H An epidemiologically significant epitope of a 1998 influenza virus neuraminidase forms a highly hydrated interface in the NA-antibody complex.	0.266	29	19	4	30	2	30	7.187E+00	10
LOKIASV2_4415_ESMFold_ribonuclease_HII	3l5w-assembly2.cif.gz_B	LOKIASV2_4415_ESMFold_ribonuclease_HII	3l5w-assembly2.cif.gz_B Crystal structure of the complex between IL-13 and C836 FAB	0.291	23	14	4	24	2	24	7.637E+00	10
